Teva Pharmaceutical Industries Ltd. (TEVA)
37.17
-0.93
(-2.44%)
USD |
NYSE |
Aug 26, 11:58
Teva Pharmaceutical Industries Total Assets (Quarterly) : 39.86B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 39.86B |
| March 31, 2026 | 40.04B |
| December 31, 2025 | 40.75B |
| September 30, 2025 | 39.86B |
| June 30, 2025 | 40.13B |
| March 31, 2025 | 38.42B |
| December 31, 2024 | 39.33B |
| September 30, 2024 | 41.76B |
| June 30, 2024 | 41.34B |
| March 31, 2024 | 42.77B |
| December 31, 2023 | 43.48B |
| September 30, 2023 | 42.09B |
| June 30, 2023 | 43.09B |
| March 31, 2023 | 43.46B |
| December 31, 2022 | 44.01B |
| September 30, 2022 | 44.25B |
| June 30, 2022 | 45.93B |
| March 31, 2022 | 47.06B |
| December 31, 2021 | 47.67B |
| September 30, 2021 | 47.85B |
| June 30, 2021 | 49.20B |
| March 31, 2021 | 49.00B |
| December 31, 2020 | 50.64B |
| September 30, 2020 | 49.74B |
| June 30, 2020 | 54.99B |
| Date | Value |
|---|---|
| March 31, 2020 | 55.33B |
| December 31, 2019 | 57.47B |
| September 30, 2019 | 57.25B |
| June 30, 2019 | 59.42B |
| March 31, 2019 | 59.85B |
| December 31, 2018 | 60.68B |
| September 30, 2018 | 65.06B |
| June 30, 2018 | 67.03B |
| March 31, 2018 | 69.18B |
| December 31, 2017 | 70.62B |
| September 30, 2017 | 86.08B |
| June 30, 2017 | 86.36B |
| March 31, 2017 | 91.27B |
| December 31, 2016 | 92.89B |
| September 30, 2016 | 98.75B |
| June 30, 2016 | 57.92B |
| March 31, 2016 | 55.13B |
| December 31, 2015 | 54.26B |
| September 30, 2015 | 48.62B |
| June 30, 2015 | 50.37B |
| March 31, 2015 | 46.95B |
| December 31, 2014 | 46.42B |
| September 30, 2014 | 46.61B |
| June 30, 2014 | 46.73B |
| March 31, 2014 | 46.89B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Johnson & Johnson | 201.06B |
| Eli Lilly & Co. | 142.28B |
| Bristol Myers Squibb Co. | 87.63B |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | 71.88M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 32.10B |
| Shareholders Equity (Quarterly) | 7.753B |
| Debt to Equity Ratio | 2.176 |
| Current Ratio | 0.8795 |
| Net Debt Paydown Yield | 0.03% |